Secretion of Ferritin by Iron-laden Macrophages and Influence of Lipoproteins

Increasing evidence supports a role of cellular iron in the initiation and development of atherosclerosis. We and others reported earlier that iron-laden macrophages are associated with LDL oxidation, angiogenesis, nitric oxide production and apoptosis in atherosclerotic processes. Here we have further studied perturbed iron metabolism in macrophages, their interaction with lipoproteins and the origin of iron accumulation in human atheroma. In both early and advanced human atheroma lesions, hemoglobin and ferritin accumulation correlated with the macrophage-rich areas. Iron uptake into macrophages, via transferrin receptors or scavenger receptor-mediated erythrophagocytosis, increased cellular iron and accelerated ferritin synthesis at both mRNA and protein levels. The binding activity of iron regulatory proteins was enhanced by desferrioxamine (DFO) and decreased by hemin and iron compounds. Iron-laden macrophages exocytosed both iron and ferritin into the culture medium. Exposure to oxidized low-density lipoprotein (oxLDL, ≥50 μg/mL) resulted in <20% apoptosis of iron-laden human macrophages, but cells remained impermeable after a 24 h period and an increased excretion of ferritin could be observed by immunostaining techniques. Exposure to high-density lipoprotein (HDL) significantly decreased ferritin excretion from these cells. We conclude: (i) erythrophagocytosis and hemoglobin catabolism by macrophages contribute to ferritin accumulation in human atherosclerotic lesions and; (ii) iron uptake into macrophages leads to increased synthesis and secretion of ferritin; (iii) oxidized LDL and HDL have different effects on these processes.

[1]  P. Lachance Overview of key nutrients: micronutrient aspects. , 2009, Nutrition reviews.

[2]  M. Davies,et al.  Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Renu Virmani,et al.  Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.

[4]  V. Bamm,et al.  Mechanism of low-density lipoprotein oxidation by hemoglobin-derived iron. , 2003, Biochemistry.

[5]  B. Halliwell,et al.  Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions. , 2003, Free radical biology & medicine.

[6]  Wei Li,et al.  The iron hypothesis of atherosclerosis and its clinical impact , 2003, Annals of medicine.

[7]  O. Tokunaga,et al.  Intracellular oxidative modification of low density lipoprotein by endothelial cells , 2002, Virchows Archiv.

[8]  B. Ersek,et al.  Impact of body iron status on myocardial perfusion, left ventricular function, and angiographic morphologic features in patients with hypercholesterolemia. , 2002, American heart journal.

[9]  J. Graversen,et al.  Haptoglobin and CD163: captor and receptor gating hemoglobin to macrophage lysosomes , 2001, Redox report : communications in free radical research.

[10]  F. Luft,et al.  Angiogenesis, Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor-BB Expression, Iron Deposition, and Oxidation-Specific Epitopes in Stented Human Coronary Arteries , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[11]  S. Shyue,et al.  Adenovirus-Mediated Heme Oxygenase-1 Gene Transfer Inhibits the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice , 2001, Circulation.

[12]  J. Keaney,et al.  Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease , 2001, Circulation.

[13]  E. H. Skiles,et al.  Role of redox-active iron ions in the decomposition of S-nitrosocysteine in subcellular fractions of porcine aorta. , 2000, European journal of biochemistry.

[14]  S. Toyokuni,et al.  Detection of lipofuscin‐like fluorophore in oxidized human low‐density lipoprotein , 2000, FEBS letters.

[15]  G. Francis,et al.  High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences. , 2000, Biochimica et biophysica acta.

[16]  C. Vrints,et al.  Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. , 1999, Cardiovascular research.

[17]  G. FitzGerald,et al.  Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C. , 1999, Circulation.

[18]  Tzong-Shyuan Lee,et al.  Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. , 1999, Circulation.

[19]  A. Paolicchi,et al.  Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation--a potential mechanism in atherosclerosis. , 1999, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[20]  Xi-Ming Yuan,et al.  Apoptotic macrophage-derived foam cells of human atheromas are rich in iron and ferritin, suggesting iron-catalysed reactions to be involved in apoptosis. , 1999, Free radical research.

[21]  J. Hinnie,et al.  Textbook of biochemistry with clinical correlations , 1999 .

[22]  J. Baffic,et al.  LDL oxidation by activated monocytes: characterization of the oxidized LDL and requirement for transition metal ions. , 1998, Journal of lipid research.

[23]  M. Noordermeer,et al.  Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients. , 1998, Blood.

[24]  Tzong-Shyuan Lee,et al.  Colocalization of iron and ceroid in human atherosclerotic lesions. , 1998, Atherosclerosis.

[25]  E. Hurt-Camejo,et al.  Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages. , 1998, Journal of Lipid Research.

[26]  S. Altamentova,et al.  Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin. , 1997, Biochemistry.

[27]  Wei Li,et al.  Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis. , 1996, Atherosclerosis.

[28]  O. Melefors Translational regulation in vivo of the Drosophila melanogaster mRNA encoding succinate dehydrogenase iron protein via iron responsive elements. , 1996, Biochemical and biophysical research communications.

[29]  A. Olsson,et al.  Macrophage erythrophagocytosis and iron exocytosis. , 1996, Redox report : communications in free radical research.

[30]  I. Akkuş,et al.  Investigation of erythrocyte membrane lipid peroxidation and antioxidant defense systems of patients with coronary artery disease (CAD) documented by angiography. , 1996, Clinica chimica acta; international journal of clinical chemistry.

[31]  A. Olsson,et al.  Effects of iron- and hemoglobin-loaded human monocyte-derived macrophages on oxidation and uptake of LDL. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[32]  A. Lusis,et al.  Lipid-induced changes in intracellular iron homeostasis in vitro and in vivo. , 1995, The Journal of clinical investigation.

[33]  M. Kendall,et al.  The oxidation hypothesis of atherosclerosis , 1994, The Lancet.

[34]  M. Aviram,et al.  Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. , 1994, Atherosclerosis.

[35]  E. Porreca,et al.  Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[36]  J. Joshi,et al.  Sequence of a cDNA encoding the ferritin H-chain from an 11-week-old human fetal brain. , 1993, Gene.

[37]  N. Gray,et al.  Translational control of 5-aminolevulinate synthase mRNA by iron-responsive elements in erythroid cells. , 1993, The Journal of biological chemistry.

[38]  O. Aruoma,et al.  Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. , 1992, The Biochemical journal.

[39]  J P Kane,et al.  Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Barbara Neupert,et al.  A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA , 1989, Cell.

[41]  M. Higgins Textbook of Biochemistry with Clinical Correlations, 2nd Edition , 1987 .

[42]  J. Sullivan IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK , 1981, The Lancet.

[43]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[44]  D. Heistad,et al.  Arteriosclerosis, Thrombosis, and Vascular Biology, 2004 , 2004 .

[45]  R. Eisenstein Iron regulatory proteins and the molecular control of mammalian iron metabolism. , 2000, Annual review of nutrition.

[46]  B. Halliwell,et al.  Metal ion release from mechanically-disrupted human arterial wall. Implications for the development of atherosclerosis. , 1995, Free radical research.

[47]  W. Morison Letter: Herpes simplex and herpes zoster in neoplasia. , 1974, Lancet.